Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Noninvasive Genetic Test for Pregnant Mothers to Check for Baby’s Health

March 31, 2014 By AB Newswire

Synapse Diagnostics, a Hyderabad based laboratory launched a new genetic blood test for pregnant mothers called Materni T21. Materni T21 PLUS is a highly accurate test for specific chromosome (Genetic) conditions in the baby associated with birth defects. It is conducted on blood collected from the mother as early as 10 weeks of pregnancy. Genetic/(Chromosomal/DNA) abnormality in the fetus (baby) such as Downs Syndrome and multiple other defects in the baby can be now detected early in the pregnant mother with this accurate and cutting edge technology. This state of the art genetic (DNA) test uses genome sequencing and provides a clear and precise result which can be easily interpreted by parents and clinicians. It is the only test in the international market that not only detects abnormalities like Downs syndrome but also defects called “Microdeletions”. These are abnormalities that are very hard to detect in a baby and parents and clinicians usually spend years after birth trying to diagnose them. With this advanced test done from the pregnant mother s blood, they can be picked up early in pregnancy.

According to Dr.Samit Sekhar who is the Managing Director for Synapse Diagnostics India, “Down’s syndrome is a naturally occurring chromosomal arrangement that has always been a part of the human condition, being universally present across racial, gender or socioeconomic lines, and affecting approximately 1 in 800 live births, although there is considerable variation worldwide. Down syndrome usually causes varying degrees of intellectual and physical disability in the baby and associated with various other medical issues”.

Currently doctors do a test from the amniotic fluid (fluid around the fetus) called amniocentesis to look for some disorders in women who are at risk such as those women who have a family history of genetic disorders. This test is done late in pregnancy and has a risk of miscarriage as it is invasive (a needle is used to take the fluid). It also cannot definitively pick up the ‘Microdeletions’ sometimes. Materni T21 provides a safe alternative for early screening without any invasive procedure or risk of losing the baby. With this technology doctors and parents can now have information very early in the pregnancy and helps to mitigate anxiety associated with more aggressive procedures or even other blood tests which may give probability based results.

The Materni T21 Plus test is developed and validated by Sequenom Center for Molecular Medicine (Sequenom CMM), a CAP accredited and CLIA-certified molecular diagnostics laboratory based in San Diego, USA.

Synapse is a Medical Laboratory chain with strategic focus on development, validation and implementation of reference technologies providing unique products and solutions that can better the nature of conventional healthcare services. Headquartered in Malaysia & now at Hyderabad, Synapse Laboratory provides unique medical testing services to hospitals and Medical Centres and clinics. With a goal to improve maternal and infant health outcomes of pregnancy, Synapse Diagnostics Pvt. Ltd. has brought this technology benefit for to India.

The launch was attended by Dr. Rachna Kairon, MD Medical director, Dr Samit Sekhar, Managing Director Synapse and a team from Sequenom, Mr Steve Quinn General manager Commercial Operations and Mr Marcos Gonzales Marketing & Medical Liaison. Synapse Diagnostics provides this test to clinics all over India.

More information on Synapse Diagnostics India can be found on synapsediagnostics.com.

Related Articles Read More >

Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices
A Medtronic HVAD pump opened up to show the inner workings
FDA designates new Medtronic HVAD pump implant recall as Class I
Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age

DeviceTalks Weekly.

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech